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The  availability  of several  murine  strains  manifesting  autoimmune  syndromes 
similar in nature to human systemic lupus erythematosus (SLE) 1 prompted extensive 
studies  on  the  immunological  abnormalities  of these  mice in  an  attempt  to  better 
understand autoimmune diseases. These studies demonstrated a wide range of abnor- 
malities  in  various  compartments  of the  immune  system,  including  the  thymus- 
derived (T) cell compartment (1, 2), 
Other recent studies suggested a central role of the antigen-nonspecific lymphokine 
T  cell  growth  factor  (3,  4),  more  recently  termed  interleukin  2  (IL-2)  (5),  in  the 
regulation of both cell-mediated and humoral T  cell-dependent immune responses (6, 
7). According to a generally accepted model (6, 7), IL-2, generated by ligand-activated 
T  cells,  regulates  the clonal expansion of antigen-stimulated  T  cells in  a  hormonal 
manner by binding to specific surface receptors on such T  cells. Because of this central 
role,  believed  to  be played by IL-2 in  regulating  T  cell  responses,  and  in  view of 
several  abnormalities  in  T  cell  function  manifested  by SLE-prone  mice  (1,  2),  we 
have analyzed in  detail patterns of IL-2 production and consumption by T  cells of 
autoimmune murine strains and their relationship to various cell-mediated immune 
responses  manifested  by  such  mice.  The  studies  reported  in  this  communication 
document  defective  patterns  of cell-mediated  immune  responses  in  autoimmune 
murine strains,  most marked in the  MRL/Mp-lpr/lpr  (MRL/I)  mouse and, specifi- 
cally, they demonstrate defects in the mode of production and consumption of IL-2 
by  T  cells  in  relation  to  their  proliferative  and  cytotoxic  T  lymphocyte  (CTL) 
responses. The most severe defects were found in older MRL/1 mice, which responded 
poorly to concanavalin A  (Con A) or allogeneic stimulator cells, generated very low 
levels of IL-2 upon Con A stimulation and responded very weakly to exogenous IL-2. 
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Whereas both spleen and lymph node cells of old MRL/1 mice gave weak proliferative 
responses  in an allogeneic MLR,  the  spleen  (but  not  lymph node)  cells generated 
normal levels of allogeneic CTL  activity and  these  findings were  corroborated  by 
direct analysis of CTL precursor frequency. 
Materials and Methods 
Mice.  The strains and sex of mice used in these experiments are listed in Results. All mice 
were obtained from the Scripps Clinic and Research Foundation mouse breeding colony. MRL 
mice of both substrains MRL/I and MRL/Mp-+/+  (MRL/n) and BXSB mice were developed 
by Dr. E. Murphy of The Jackson Laboratory, Bar Harbor, Maine. Unless otherwise stated, 
young donors were 4-6 wk old and "old" mice were 4-6 mo of age.  Information about the 
derivation and mortality rates  of these strains as well as  their histoimmunopathologic and 
serologic characteristics has been detailed elsewhere  (1, 2). 
Cell Preparation.  Lymph nodes and spleens were aseptically removed from donor mice and 
single cell suspensions were prepared by teasing the organs in a glass homogenizer with a loosely 
fitting pestle.  Spleen cell suspensions were treated briefly with an ammonium chloride buffer 
to  lyse  erythrocytes and  viable cells  were  enumerated using 0.1% trypan blue. Cells were 
resuspended at the desired concentration in RPMI  1640 medium supplemented with 2 mM 
glutamine, 1 mM sodium pyruvate,  1% penicillin-streptomycin  solution, 5% fetal calf serum 
(FCS)  (all  from  Irvine Scientific, Santa Ana, Calif.),  and 5  X  10  -~  M  2-mercaptoethanol 
(Eastman Kodak Co.,  Rochester,  N.  Y.).  Cells were  cultured in this medium in a  5%  CO2 
humidified incubator at 37°C. 
IL-2 Production.  Cells were resuspended in culture medium containing 2.5 or 5 p.g/ml Con 
A  (Miles-Yeda, Rehovot, Israel)  at 5 X  106/ml  and volumes of 10 ml were added to 25-em  2 
tissue culture flasks (3013; Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.). 
In some experiments, control cultures lacking Con A  were  also established. Cultures were 
harvested after 24, 48, or 72 h and the supernates, obtained by centrifugation at 1,500 g for  15 
min, were sterilized in 0.45-#m filters  (Millipore Corp., Bedford,  Mass.)  and kept at 4°C until 
assayed. 
IL-2 Bioassay.  IL-2 activity was quantitated in a bioassay (8) using cells of the long-term, 
IL-2-dependent CTL line, CTLL-2 (obtained from Dr. J. Watson, Irvine, Calif.) as indicator 
cells (4). This cell line was maintained in culture medium supplemented with 25-50% crude rat 
IL-2 and passed twice weekly at initial cell concentrations of 5 X  103-10 X  103/ml. CTLL-2 
cells were washed once in IL-2-free medium and cultured in flat-bottomed microtiter plates 
(3040;  Falcon Labware)  at  1 X  104/0.2 ml of medium containing serial (three-  or fourfold) 
dilutions of culture  supernates  to  be  tested  for  their  IL-2  activity.  A  standard  rat  IL-2 
preparation was used as a reference in most experiments. Cultures were pulsed after 20 h with 
1 #Ci [3H]TdR (5 Ci/mmol; Amersham Corp., Arlington Heights, Ill.), harvested 4 h later on 
a Titertek cell harvester (Flow Laboratories, Rockville, Md.) and counted in a liquid scintillation 
counter. The response was quantitated by probit analysis (8) and one unit of IL-2 activity was 
defined as the amount of IL-2-containing  crude culture supernate that produced 50% of the 
maximal proliferative response generated by the reference IL-2 preparation. The IL-2 activity 
in units per milliliter  was derived from that amount. 
Con A-induced Mitogenic Response.  100-pJ aliquots of control or Con A-stimulated cultures 
were transferred after 24, 48, or 72 h ofcuhure in 25-cm  2 flasks (established as described above) 
into flat-bottomed mierotiter plates and pulsed for 4  h  with  1 /~Ci [3H]TdR. Alternatively, 
cultures were set in microtiter wells with various numbers of spleen or lymph node cells, usually 
2.5 X  105/well, in 200/tl of culture medium without or with 2.5/~g/ml Con A. Cultures were 
pulsed after 24, 48, or 72 h and harvested 4 h later as described above. 
IL-2 Adsorption.  Cells used for adsorption of IL-2 were 48-h Con A-stimulated spleen cells. 
The cells were washed three times in serum-free RPMI 1640 medium with 30 rain incubation 
at 37°C between washes. The cells were then resuspended in 0.5 ml of mouse IL-2 preparations 
and this suspension was incubated for 2 h  at  37°C with occasional shaking. The supernate, 
obtained by centrifugation at  1,500  g for  15 min, was assayed for residual IL-2 activity in the 
bioassay described above. ALTMAN ET AL.  793 
Mixed Lymphocyte Reaction (MLR).  The MLR was performed as described before (9). Briefly, 
2 ×  105 responding and 2.5 or 5 ×  105 irradiated stimulator spleen cells in 200 ~1 medium were 
cultured for a total of 72 h in flat-bottomed microtiter plates, pulsed with  1 #Ci [aH]TdR for 
the final 24 h, harvested, and counted as described above. 
CTL  Induction and  Cell-mediated Lympholysis (CML)  Assay.  CTL  were  induced  in  a  5-d 
allogeneic MLR and assayed for their cytolytic activity in a CML assay as described before (9). 
Briefly,  2  ×  106 each  of responding  and  3,000  rad-irradiated  stimulator  spleen  cells  were 
cultured in 1 ml medium in 35-mm tissue culture dishes on a rocking platform for 5 d. CML 
was assayed by adding 1 ×  104 5tCr-labeled Con A-stimulated lymphoblasts to the cultures and 
harvesting the cultures 4 h later. 
Determination of CTL Precursor (CTLp) Frequency.  Determination  of alloreactive CTLp fre- 
quency was performed using a limiting dilution assay, similar to those described by others (10- 
12).  Limiting  numbers  of MRL/I  or  C3H/St  lymph  node or spleen  responder  cells  were 
cultured  (at  24  replicate  wells  per  responder  cell  dose)  with  5  ×  105  2,000  rad-irradiated 
allogeneic C57BL/6 (H-2  b) spleen cells in 0.2 ml/well of extra high amino acids medium (13) 
supplemented with 10% FCS and 25% (vol:vol) of a rat IL-2-containing supernate. The Con A 
in this supernate  was blocked by the addition  of 20 mg/ml a-methyl-n-mannoside (aMM) 
(Sigma Chemical Co.,  St.  Louis, Mo.).  Preliminary experiments established  that:  (a)  aMM 
effectively blocked the mitogenic effect  of the residual Con A on fresh thymocytes or spleen 
cells;  (b) the aMM itself had no effect on the induction of alloreactive CTL; (c) in the absence 
of exogenous IL-2, no CTL responses were generated by the low numbers of responder cells 
used; and (d) responder cells cultured with IL-2 only, in the absence of allogeneic stimulators, 
failed to generate CTL activity. Cultures were set in round-bottomed microtiter plates (76-011- 
05; Linbro Scientific, Inc., Hamden, Conn.)  for 7 d, after which  100 #1 of the spent culture 
3  3  51  medium was drawn from each well and 2 ×  10 -5 ×  10  Cr-labeled EL4 (H-2b)target cells in 
100 #1  fresh  RPMI  1640  plus  5%  FCS  were  added  to each  well.  After an  additional  4  h 
incubation  at  37°C,  100 #1 of supernate was removed from each well  for gamma counting.  5~  Spontaneous  Cr release was established in 24 cultures that contained only stimulator cells and 
IL-2. Cultures were considered positive for cytolytic activity when the  Cr release  in a given 
well exceeded the mean spontaneous release value by at least  three standard deviations of the 
mean. The frequency of the CTLp was calculated by plotting the percent of nonresponding 
cultures vs. the number of responder cells per well  (10-12). 
Results 
Con  A-induced Mitogenic Responses.  Fig.  1  shows  the  Con  A-induced  mitogenic 
responses of the SLE strains and their normal counterparts.  Among the young mice, 
MRL/I  (panel A)  and male BXSB  (panel  B)  showed a  defective response at  1.5  mo 
of age. All other young SLE (as well as normal) strains between  1 and 2.5 mo of age 
gave normal mitogenic responses. 
The responses  of the early, severe  SLE-developing strains  MRL/I  (panel  A)  and 
male BXSB  (panel  B)  were greatly reduced at 4-4.5  mo of age compared with age- 
matched  immunologically normal strains  of mice.  In contrast,  the responses of late, 
mild SLE-developing MRL/n  (panel A) and female BXSB (panel B) mice at similar 
age were within normal limits.  NZB and (NZB ×  NZW)F1 hybrid (BWF  0  mice at 5- 
6.5 mo of age were normal  in this respect  (panel C);  however, at  7.5 mo of age, the 
female (but not male) BWF1 mice gave a markedly reduced mitogenic response (panel 
D).  Similarly,  the responses of MRL/n  mice tested  at 8-8.5  mo of age were greatly 
reduced, being only 25-30% of the normal ones (results not shown). 
IL-2 Levels in  Culture Supernates.  The  levels  of IL-2 in  unstimulated  and  Con A- 
stimulated  culture supernates of spleen cells derived from various mouse strains were 
determined  using  the  bioassay  described  in  Materials  and  Methods  (8).  Culture 
supernates were harvested after  1, 2, or 3 d  and serial dilutions were assayed for their 794  INTERLEUKIN  2 DEFECTS IN AUTOIMMUNE  MICE 
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Fie.  1.  Con A-induced mitogenic responses of spleen cells from normal and autoimmune murine- 
strains. Uptake was determined after 1, 2, or 3 d of stimulation after a 4-h pulse with 1 /xCi [aH]- 
TdR. Net [3H]TdR uptake levels after subtraction of uptake in control and unstimulated cultures 
(12,000 cpm or less) are shown. Numbers in the figure panels represent the age of the cell donors in 
months. 
IL-2 activity. Supernates  of control cultures,  not stimulated with Con A, displayed 
some IL-2 activity in some but not all cases; however, this activity, possibly induced 
by  FCS  stimulation,  never  exceeded  2%  of the  IL-2  activity  in  parallel,  Con  A- 
stimulated culture supernates. Furthermore, spleen cells of autoimmune mice did not 
spontaneously secrete into their culture supernates more IL-2 than did spleen cells of 
normal mice (data not shown). 
The results of such analyses, repeated  at  least twice for most strains studied,  are 
summarized  in  Table I.  Although  the  IL-2 levels in  stimulated  culture  supernates 
derived  from  normal  strains  are  highly  variable,  it  is  still  evident  that  culture 
supernates of4-5-mo-old MRL/1 and male (but not female) BXSB and female BWF1 
mice  at  5.5  mo  of age  contain  markedly  lower  levels  of IL-2  activity.  Similarly, 
stimulated culture supernates of MRL/n mice at 8.5 (but not at 5.5; data not shown) 
mo of age show decreased levels of IL-2. On the other hand, normal IL-2 levels were 
found in supernates derived from 4.5-5-mo-old NZB mice. With respect to the young 
mice, decreased  levels of IL-2 were consistently found  in Con  A-stimulated culture 
supernates of MRL/1 mice and in 48- (but not 24-) h culture supernates of spleen cells 
from  young  (6-wk-old)  male  BXSB  mice,  whereas  spleen  cells  of all  other  young 
autoimmune murine strains produced normal levels of IL-2. 
A  detailed  analysis indicated  that  the defects in  IL-2 production were evident  in 
the spleens of young MRL/I mice at  1,  3,  4,  and  5 wk of age and IL-2 levels were 
much lower than in culture supernates of C3H/St spleen cells of parallel ages (Fig. 2). 
This  early  reduction  in  IL-2  levels  was  not  associated  with  lymphoproliferation ALTMAN  ET  AL. 
TABLE  I 
IL-2 Levels in Con A-stimulated Spleen Cell Culture Supernates of 
Autoimmune and Normal Murine Strains* 
IL-2 level (U/ml) in culture super- 
nates~ 
H-2 haplo-  Strain and sex  type  Day  1  Day 2 
Young  Old  Young  Old 
Normal strains 
C3H/St (3  k  330  910  250  800 
C57BL/6 d  b  270  120  55  270 
BALB/c ~  d  780  530  60  95 
Autoimmune strains 
MRL/I 9  k  100  []  §  ~  [~ 
MRL/n 9  k  390  [~  160  []~] 
BxsB d  +  28o  []  []  ~1 
BXSB 9  b  220  170  220  240 
NZB ~  d  130  335  50  230 
BWF, ~?  d/z  140  [~T]  80  [] 
* Summary of five separate experiments. Young mice were 4-6 wk old and old 
mice were 4-6 mo old, except the MRL/n mice, which were 8.5 mo old. 
:~ IL-2 levels in 3-d culture supernates were, in almost all cases, <1 U/ml. 
§ Boxed  numbers  are  markedly  below  the  range of IL-2  levels  in  normal 
strains. 
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Fz6.  2.  II  2 activity in Con A-stimulated spleen cell culture supernates derived from C3H/St and 
MRL/! mice of various ages. Culture supernates were harvested after t  or 2 d of stimulation with 
2.5 #g/ml Con A in 16-ram wells  (5 X  106 ceUs/ml per well) and assayed in a standard IL-2 assay. 
Numbers in parentheses indicate the yield of viable nucleated cells per spleen (× 106). 
because the numbers  of nucleated  cells recovered from the spleens of MRL/I  mice up 
to 5  wk of age were very similar to those of age-matched  C3H/St  mice (Fig.  2). 
Effect of Culture Conditions on Responses of MRL/ l Mice.  The defects in Con A-induced 796  INTERLEUKIN  2 DEFECTS IN AUTOIMMUNE MICE 
mitogenic response and IL-2 production manifested by MRL/I mice even at a young 
age were somewhat surprising in view of the massive and selective T  cell proliferation 
that this strain manifests (1, 2). Therefore, we decided to focus our subsequent studies 
on clarifying the  mechanisms underlying  the  defective IL-2 response in  this  strain. 
One possible explanation for these defects was simply inadequate culture conditions, 
e.g.,  suboptimal  concentrations  of responding  cells  or  Con  A.  However,  results  of 
several experiments  (data  not  shown)  revealed that  the severe defects in  rnitogenic 
response and IL-2 production were consistent across a wide range of mitogen (1.25-20 
/~g/ml) and cell (0.625-10  x  106/ml) concentrations. 
The Role of Suppressor Cells in Defective Responses of Old MRL/ l Mice.  Cultured spleen 
cells, either without  or with Con A  stimulation, were shown  to generate suppressor 
cells  that  can  manifest  their  suppressive  activity  in  a  variety  of systems  (14-16). 
However, examination, by cell mixture studies, of spleens of old MRL/I mice for cells 
that would suppress the Con A-induced proliferative responses and IL-2 production 
by functionally normal spleen ceils from young C3H/St,  MRL/n,  or MRL/I mice, 
failed to reveal any significant suppressor cell activity (data not shown). Thus, it can 
be concluded  that  under  our experimental conditions,  suppressor cell  activity does 
not appear to play a major role in defective IL-2 production by MRL/I T  cells. 
Search for  a  Suppressive  Material  in  Stimulated  Culture Supernates of  Old  MRL/l 
Mice.  Soluble nonspecific suppressive molecules were reported to be induced  upon 
stimulation  of lymphoid  cells with  Con  A  (17).  In  addition,  it  has been suggested 
recently  that  such  molecules  may act  as  antagonists  that  regulate  IL-2 action  on 
activated T  cells (18).  This raises the possibility that the apparent deficiency of IL-2 
in  Con  A-stimulated  culture  supernates  of old  MRL/1  spleen  cells  ma,] be due  to 
abnormally high levels of some suppressive material(s), which inhibits IL-2 production 
or action.  To study  this  possibility, we added  increasing  amounts  of 24-h  Con  A- 
stimulated spleen cell culture supernates of old MRL/I  (or control C3H/St)  mice to 
a standard optimal dose (10% vol:vol) of an active C3H/St-derived IL-2 preparation. 
The IL-2 activity in these mixed supernates was measured in a standard IL-2 bioassay 
(Fig.  3).  Direct  titration  of [L-2  activity clearly  revealed  that  the  MRL/1-derived 
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Fro.  3.  Lack  of soluble suppressor material(s) in  Con  A-stimulated culture supernates of old 
MRL/1-derived spleen cells. In panel A, a direct titration of IL-2 activity in C3H/St- and MRL/I- 
derived Con A-stimulated culture supernates is shown. Panel B: different dilutions of C3H/St- and 
MRL/l-derived culture supernates were added to a standard dose (10% vohvol) of an active, C3H/ 
St-derived IL-2 preparation. ALTMAN  ET  AL.  797 
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F1o.  4.  The effect of exogenous IL-2 on the Con A-induced mitogenic response of C3H/St  and 
MRL/I mice. 2.5 ×  l0  s C3H/St spleen cells or MRL/I spleen or lymph node cells from 6-too-old 
mice were stimulated with 2.5 #g/ml Con A in the absence (1:00) or presence of various dilutions 
of a  C3H/St-derived IL-2 preparation.  [3H]TdR  uptake was determined 48 h  after a  4-h pulse. 
[aH]TdR  uptake  values by control, unstimulated cultures  (C3H/St  spleen:  10,073  cpm; MRL/I 
spleen: 1,793 cpm; MRL/I lymph nodes: 1,339 cpm) were subtracted to give the net levels of uptake 
shown.  6-too-old  responders:  0,  old  C3H/St  spleen  cells;  &,  old  MRL/I  spleen  cells;  II,  old 
MRL/I lymph node cells. 
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FIo.  5.  Lack of IL-2 adsorption by Con A-stimulated MRL/l-derived spleen cells. A  BALB/c- 
derived IL-2 preparation was titrated before or after adsorption for 2 h at 37°C on 7 X  107 fresh or 
Con A-stimulated spleen cells as shown. Spleen cells used for adsorption were obtained from 6 mo- 
old mice: O, none; A, 7 x  107 fresh C3H/St; II, 7 x  107 Con A-stimulated C3H/St; V, 7 X  l0  T  Con 
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culture supernate  was  markedly  deficient  in  IL-2 activity in  comparison with  the 
C3H/St-derived supernate  (Fig.  3, panel A). As shown  in panel B, the addition of 
MRL/1 or C3H/St-derived culture supernates  had  very similar effects on the IL-2 
activity of 10% (vol:vol) C3H/St-derived IL-2. Similar results were obtained with 2- 
or 3-d Con A-stimulated culture supernates (data not shown). These results demon- 
strate that culture supernates of stimulated  old MRL/l-derived spleen cells do not 
contain unusual amounts of substances that act as a specific IL-2 antagonist(s). 
Response of Old MRL/l Lymphocytes to Exogenous IL-2.  The results presented so far 
strongly suggest  an  intrinsic defect in  IL-2 production by T  cells of MRL/I  mice. 
Because IL-2 stimulates  activated T  cells to proliferate by binding to specific cell- 
surface receptors (7,  19, 20), we next asked whether spleen or lymph node cells of old 
MRL/1  mice  can  respond  normally  to  IL-2.  We  predicted  that  if cells  bearing 
receptors  for and  capable  of responding  to  IL-2  exist  in  MRL/I  mice  in  normal 
proportions, then the addition of an exogenous active source of IL-2 would bypass the 
defective IL-2 production and allow a normal Con A response. 
The results of such an experiment, using an active C3H/St-derived IL-2 prepara- 
tion, are summarized in Fig. 4. Because this IL-2 preparation itself contained Con A 
(at 5/zg/ml), it was diluted in Con A-containing (5 #g/ml)  fresh culture medium to 
keep the mitogen concentration constant (at a final dose of 2.5 #g/ml) in all cultures. 
Thus, the only variable is the amount of exogenous IL-2 added to the cultures. The 
results  (Fig.  4)  clearly  demonstrate  that  although  IL-2  was  capable  of strongly 
potentiating the already substantial  Con A reactivity of C3H/St spleen cells, it did 
not  restore the response of lymph node or spleen cells of 6-mo-old MRL/I mice to 
normal  levels. Thus,  T  cells  of MRL/1  mice  appear  to be  relatively incapable  of 
responding to IL-2. 
Taken  together,  the  results  presented  so  far  clearly  indicate  that  the  deficient 
mitogenic response of old MRL/I  T  lymphocytes upon Con A  stimulation  reflects 
defects in both the production of and the response to IL-2. 
IL-2 Adsorption Studies.  The deficient response of Con A-stimulated lymphocytes of 
old MRL/I mice to exogenous IL-2 (Fig. 4) could be explained by several mechanisms, 
among them failure to bind, or the degradation and inactivation of IL-2 by the cells 
before triggering can occur. In both cases, the final outcome would be manifested as 
a  lack of proliferative response  to exogenous IL-2.  To determine whether Con  A- 
incubated spleen cells of old MRL/1 mice can remove IL-2 from a biologically active 
supernate or degrade IL-2 activity, we titrated IL-2 preparations  for their residual 
biological  activity  after  adsorption  on  fresh  or  Con  A-stimulated  old  MRL/I  (or 
control C3H/St)-derived spleen cells (Fig. 5). 
As expected, fresh C3H/St spleen cells did not absorb IL-2 activity to any significant 
degree when compared with  the unadsorbed  IL-2 preparation  (Fig.  5).  Conversely, 
the  Con  A-stimulated  C3H/St  spleen  cells  removed  almost  completely  the  IL-2 
activity from the supernate, in agreement with their ability to respond normally to 
Con  A  stimulation.  In  contrast,  the  IL-2  preparation  retained  its  full  biological 
activity after incubation with spleen cells of old MRL/I mice that had been exposed 
for 2  d  to Con  A.  The lack of IL-2 adsorption  by these cells was  not  unexpected 
because as shown above, T  cells of older MRL/I mice fail to respond to Con A, either 
in  the  absence  (Fig.  1)  or presence  (Fig.  4)  of exogenous IL-2. The results  clearly 
indicate, however, that spleen cells of older MRL/1 mice do not degrade or otherwise 799 
250- 
TABLE II 
Allogeneic MLR of MRL/ I, MRL/n, and C3H/St-derived Spleen Cells 
against BALB/c (H-2  a) Stimulator Spleen Cells* 
Strain and age  Net [aH]TdR uptake:~  Stimulation index 
A cpm 
MRL/I, young  151,770  10.1 
MRL/n, young  210,483  6.8 
C3H/St, young  208,583  10.0 
MRL/I, old  ~  § 
MRL/n, old  83,060  8.2 
C3H/St, old  125,341  9.1 
* 2  X  105  responder  spleen  cells  were  cultured with  2.5  X  105  irradiated 
syngeneic  or  allogeneic  BALB/c  spleen  cells  and  [aH]TdR  uptake  was 
determined on the 3rd d of culture. VH]TdR uptake by irradiated stimulator 
cells alone was _<1,000 cpm. 
:~ [aH]TdR uptake by allostimulated cultures minus that in cultures containing 
syngeneic stimulator cells. 
§ Boxed numbers represent a deficient response, 
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Fro.  6.  Kinetics of the anti-C57BL/6 (H-2  b) MLR by spleen and mesenteric lymph node cells of 
4-mo-old C3H/St and MRL/I mice. 2.5 ×  105 responder cells were cultured with 5 ×  105 irradiated 
(2,000 rad) syngeneic or allogeneic C57BL/6 spleen cells and harvested  on the days indicated after 
a  16-h pulse with 1/tCi  [aH]TdR.  Net levels of isotope uptake after subtraction of [aH]TdR uptake 
in cultures with syngeneic  stimulators are shown.  C3H/St:  O,  mesenteric  lymph node cells; &, 
spleen cells. MRL/I: O, mesenteric lymph node cells; A, spleen cells. 
inactivate IL-2.  Interestingly, fresh  (not Con A-stimulated) proliferating spleen cells 
from the enlarged spleens of MRL/1 mice also failed to adsorb IL-2 from a biologically 
active supernate (data not shown). 
Alloantigen Reactivity of MRL/I Spleen Cells.  As another parameter of T  cell reactiv- 
ity, we next studied  the alloantigen reactivity of MRL/I  T  lymphocytes because the 800  INTERLEUKIN  2  DEFECTS  IN  AUTOIMMUNE  MICE 
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F[c.  7.  Exogenous IL-2 does not reconstitute to normal levels the deficient MLR of MRL/I lymph 
node and spleen cells against C57BL/6 stimulator cells. Mesenteric lymph node or spleen cells of 4- 
too-old C3H/St or MRL/1 mice were cultured at the numbers indicated in the abscissa with 5 ×  10  s 
irradiated (2,000 rad)  syngeneic  or allogeneic  C57BL/6 spleen cells in the absence or presence of 
10%  (vol:vol) crude IL-2 derived from rat spleen cell cultures stimulated for 48 h with 2.5 ~g/ml 
Con  A.  The  Con  A  in  the  ]L-2  preparation was blocked by  adding 20  mg/ml aMM,  which 
completely blocked the mitogenic effect  of this preparation on fresh  thymocytes or spleen cells. 
Cultures were harvested after 4 d, following a  16-h pulse with 1/~Ci [aH]TdR.  Net [aH]TdR  uptake 
after subtracting the levels of uptake in control cultures (with syngeneic stimulators)  is shown. 
TABLE  III 
Allogeneic CTL Responses of MRL/l and C3H/St Mice 
Responder spleen  Stimulator spleen cells  CML activity, per- 
cells  (3,000 rad)  cent specific lysis ± 
SE* 
Young MRL/1  BALB/c  83.7 ±  2.6 
Old MRL/I  BALB/c  81.3 +  2.1 
Old C3H/St  BALB/c  87.0 ±  0.6 
Young MRL/I  C57BL/6  81.2 ±  3.1 
Old MRL/I  C57BL/6  91.2 ±  1.4 
Old C3H/St  C57BL/6  78.6 ±  3.3 
Young MRL/I  SJL  89.8 ±  1.1 
Old MRL/I  SJL  87.9 ±  3.0 
Old C3H/St  SJL  87.5 ±  3.9 
Young MRL/1  BALB/c "~ (Anti-Thy-  1.2  74.5 ±  7.6 
Old MRL/I  BALB/c ~,  plus comple-  77.9 ± 6.6 
Old C3H/St  BALB/eJ  ment treated)~  77.3 ±  6.1 
* CML activity was assayed  against target cells syngeneic to the stimulator 
cells in each case. Spontaneous 51Cr release values were 23.4, 26.1, and 29.5% 
for the BALB/c, C57BL/6, and SJL target cells, respectively. 
2 X  10  s stimulator cells treated with 1 ml anti-Thy-l.2 ascites fluid (for 30 
min at 4°C), followed by guinea pig complement (1:6 dilution, for 40 min at 
37°C).  These cells were reduced in their capacity to respond to Con A by 
94% relative  to the unfractionated starting population. ALTMAN ET AL.  801 
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FIG.  8.  Analysis of anti-C57BL/6  (H-2  b) CTLp frequency in mesenteric lymph nodes or spleens 
of 4-too-old C3H/St and MRL/I mice. Various numbers of responder cells as shown were cultured 
with 5 ×  105 irradiated C57BL/6 spleen cells and 25%  (vohvol) aMM-blocked Con A-stimulated 
rat spleen cell culture supernate as a source of IL-2 activity. SXCr release was determined after 7 d 
by  adding  2  X  l0  n  labeled  EL4  (//-2  ~)  target  cells  and  harvesting  the  supernates  4  h  later. 
Spontaneous 5XCr release was 17.1 ±  1.5%. 
proliferative response of T  lymphocytes in an allogeneic MLR is believed to involve 
the  production  and  action  of  IL-2,  and,  furthermore,  IL-2-1ike  helper  factor(s) 
produced ir~  an  MLR  appear  to be required  for optimal  induction  of alloreactive 
CTL (21-26). Both alloantigen-induced proliferation and the induction of CTL were 
analyzed and a comparison was made between young and old MRL/I, MRL/n, and 
C3H/St mice. 
The proliferative allogeneic responses of the various strains tested in one of three 
representative experiments are summarized in Table II. It is evident that  although 
spleen cells of young (8-wk-old) MRL/1 mice, as well as spleen cells of young or old 
MRL/n mice, manifested normal MLR reactivity in comparison with C3H/St spleen 
cells (as well as other normal strains;  data not shown), the spleen cells of old MRL/1 
mice were highly deficient. The experiment summarized in Fig. 6 demonstrates that 
this deficient proliferation in the  allogeneic MLR  was  consistent when  cultures of 
either lymph node or spleen responder cells were harvested daily between 3 and 7 d 
after culture initiation. This indicates that the deficient MLR reactivity manifested 
by T  cells of old MRL/I mice is not due simply to altered kinetics of the response. 
The deficient MLR reactivity of spleen or lymph node cells from old MRL/I mice 
could not be reconstituted to normal levels by adding to the cultures an exogenous 
rat-derived  IL-2.  As  shown  in  Fig.  7,  although  IL-2  was  capable  of augmenting 
substantially the MLR responses of C3H/St lymph node and particularly spleen cells, 
it failed to restore to normal levels the low responses of either lymph node or spleen 
cells of 4-mo-old MRL/I mice. 
Table  III  summarizes  the  CTL  responses  generated  in  cultures  of C3H/St  or 802  INTERLEUKIN  2  DEFECTS  IN  AUTOIMMUNE  MICE 
MRL/I spleen or lymph node cells stimulated with irradiated allogeneic spleen cells. 
These  results  demonstrate  that  spleen  cells  derived  from  old  (as  well  as  young) 
MRL/I mice generated CTL responses, comparable  to  those of old C3H/St  cells, 
against  stimulators of three different H-2 haplotypes. This finding was  somewhat 
surprising in view of the deficient IL-2 production and MLR reactivity by spleen cells 
of old MRL/I mice. Several investigators (21-26)  have demonstrated that the gener- 
ation of allogeneic CTL responses requires helper T  cells acting via release of IL-2, 
which in turn provides an amplifying signal to  the CTL precursors.  Because IL-2 
production  is known to be radiation resistant  (26,  27),  it was possible that T  cells 
within the irradiated stimulator spleen cell population generated the IL-2 required 
for CTL generation. This possibility is most unlikely because irradiated stimulator 
BALB/c spleen cells depleted of T  lymphocytes stimulated all three responder cell 
types (Table III). 
The final possibility was that because these CTL responses were generated in bulk 
cultures, CTLp were present in excess and therefore we were measuring CTL activity 
at  a  high effector to  target  cell ratio,  possibly in  the  plateau  region of the  dose- 
response curve. Thus, we determined the frequency of alloreactive CTLp by limiting 
dilution. As shown in Fig. 8, although the frequency of anti-C57BL/6 (H-2  b) CTLp 
in the spleens of 4-mo-old MRL/1 mice was similar to that in C3H/St lymph nodes 
or  spleen  (1/710  vs.  1/960  and  1/860,  respectively),  the  CTLp  frequency  in  the 
mesenteric lymph nodes of MRL/I mice was by far lower (1/11,875). These findings 
are  interesting  for  two  reasons.  First,  the  CTLp  frequency  in  the  spleen  of old 
MRL/1 mice is normal despite the fact that it contains three to four times higher 
numbers of total nucleated cells and a two to three times higher proportion of T cells 
than found in a  normal spleen  (28).  Second, MRL/I spleen cells generate normal 
alloreactive CTL responses despite their marked defect in alloantigen-induced prolif- 
eration (Table II; Fig. 6). 
Discussion 
Mice with SLE-like syndromes manifest a wide spectrum of abnormalities in T and 
B cell distribution and function (1, 2). However, the pathogenic importance of some 
of these abnormalities remains questionable. Moreover, with the single exception of 
a  generalized B cell hyperactivity observed in all of these mice, no other universally 
expressed  lymphoid cell  abnormality has  been  described.  In  this  study, we  have 
analyzed various  parameters  of production  of and  response  to  the T  cell-derived 
immunoregulatory lymphokine, IL-2,  in  SLE-prone  mice.  IL-2  appears  to  play a 
central  role  in  the  control  of activated T  cell  proliferation  (6,  7)  and,  therefore, 
abnormalities in its production or the response to it should be reflected in abnormal 
patterns  of cell-mediated immunity as  well  as  antibody responses  that  require  T 
helper cells. In addition, we have analyzed some other cell-mediated functions in these 
mice, namely, the mitogenic responses to Con A  and allogeneic stimulator cells,  as 
well as the induction of alloreactive CTL responses. 
Our results demonstrate a decline of Con A-induced mitogenesis and consequently 
IL-2 production in most SLE strains studied. The concomitant decrease of Con A 
responsiveness and of IL-2 production is not surprising because the proliferation of T 
cells appears to be mediated by IL-2, which in turn is secreted by Con A-activated T 
cells (6, 7). In general, there appears to be a correlation between the severity and time ALTMAN ET AL.  803 
of onset of the SLE syndrome and reduction in Con A activation and IL-2 production. 
Thus, mice expressing late-onset disease (BWF1, female BXSB, and MRL/n) have a 
delayed reduction occurring at or just before the clinical onset of disease. In contrast, 
mice  that  develop early and  severe disease  (MRL/I  and  male  BXSB)  exhibit  the 
defect early in life. The pathogenic importance of this abnormality in mice developing 
late disease remains  questionable because generalized B  cell hyperactivity and  au- 
toantibody production are observed in such mice much earlier than  the decline in 
Con A  responsiveness and IL-2 production. The decline of these T  cell functions in 
NZ mice may merely reflect the altered composition of their lymphoid compartment 
and  the  reduced  numbers  of T  cells  observed  with  age  in  such  mice  (28-31). 
Furthermore, reductions in Con A-induced mitogenesis and IL-2 production do not 
appear to be due to direct or indirect effects of natural  thymocytotoxic antibodies 
(NTA) observed in the sera of some SLE strains (30). This conclusion is based on the 
lack of correlation between appearance of NTA and the reduced Con A responsiveness 
and IL-2 production. The first appears very early in the life of NZ mice (32), whereas 
the other two appear late.  In addition,  MRL/1 mice, which to a  large degree lack 
detectable  levels  of  NTA  (32),  exhibit  the  most  pronounced  deficit  in  Con  A 
responsiveness and IL-2 production. 
We are left, therefore, with two SLE strains in which the pathogenic importance of 
reduced Con A reactivity and decline in IL-2 production needs to be considered, i.e., 
the  MRL/I  and  male  BXSB  mice.  In  both  MRL/I  and  male  BXSB  mice,  the 
reduction  in  these  T  cell  functions  is  observed relatively early  in  life,  before any 
clinical signs of disease. The decline becomes much more evident at or a little before 
the full clinical expression of disease. In the male BXSB mice, a decline in these T cell 
functions may be explained in part by the dilution of Con A-responding T  cells by 
other, non-T cells.  Older male BXSB mice exhibit a considerable degree of lymphoid 
hyperplasia due to B cell proliferation. As a result, there is an approximately threefold 
decrease in the frequency of T  cells in the spleen or lymph nodes (28).  However, the 
defects in mitogenic response and IL-2 production manifested by spleen cells of older 
male BXSB mice appear to be too profound to be explained entirely on the basis of 
the reduction in T  cell frequency. Furthermore, increasing the spleen cell concentra- 
tion in culture to relatively high densities did not overcome these defects (results not 
shown). Whether a selective loss (or decrease) of a particular T  cell subset(s) occurs in 
older male BXSB mice is not yet known.  Despite the profound decrease in Con A 
responsiveness and IL-2 production in older male BXSB mice, T  cells of such mice 
perform normally in other ways such as alloreactivity, generation of cytotoxic cells 
after viral infection, and clearance of Listeria monocytogenes after systemic infection (33), 
as well as antigen-specific and antigen-nonspecific T  cell suppression (1, 2). 
The defective Con A-induced mitogenic responses and  IL-2 levels manifested by 
MRL/I mice are somewhat surprising in view of the massive T  cell proliferation that 
occurs in these mice (2, 28, 34). In fact, if IL-2 is the "universal" biologic mitogen for 
activated T  cells, as has been suggested (6,  7), then one might expect an abnormally 
high level of IL-2 production by MRL/I T  cells.  However, the data presented here 
clearly demonstrate that this is not the case. 
The possibility that lymphoid cells in older MRL/I mice suppress IL-2 production 
and/or proliferative responses was excluded because the addition of spleen cells from 
older MRL/1 mice to spleen cell cultures of young syngeneic, eongenic (MRL/n), and 804  INTERLEUKIN 2 DEFECTS IN AUTOIMMUNE MICE 
histocompatible normal mice (C3H/St)  did not result in decreased IL-2 production 
by the latter cell types. Similarly, our experiments failed to demonstrate a  soluble 
suppressor material(s) in Con A-stimulated culture supernates of older MRL/I mice. 
Therefore, the combined results exclude the possibility that  the reduced IL-2 levels 
manifested by MRL/1 mice result from cells or substances that can inhibit IL-2 action 
or inactivate it. 
These studies also established that, in addition to defective IL-2 production, T cells 
of MRL/1 mice fail to respond in a normal manner to exogenous IL-2 when incubated 
together with Con A or allogeneic cells.  This relative lack of response to IL-2 could be 
explained by several mechanisms, among them the relative lack of surface receptors 
for IL-2  or  the  degradation  of IL-2,  e.g.,  by some  enzyme(s).  Adsorption  studies 
demonstrated  that  IL-2-containing  culture  supernates  retained  their  full  biologic 
activity after incubation  with  fresh  or Con  A-stimulated  MRL/1  splenocytes;  this 
contrasted with the ability of Con A-activated C3H spleen cells to adsorb  all  IL-2 
activity  from  the  same  preparation.  Taken  together  with  the  above  co-culture 
experiments, this finding strongly suggests that unstimulated or mitogen-stimulated 
spleen cells of older MRL/I mice have a  relative lack of IL-2 receptors and do not 
inactivate IL-2 molecules. The fact that the massively proliferating T  ceils found in 
MRL/I mice do not respond to or adsorb exogenous IL-2 may suggest that the in vivo 
proliferation of these cells is IL-2 independent, as has recently been suggested in the 
case of leukemic T  cells (35). 
In  addition  to  reduced  Con  A  reactivity, older  MRL/I  mice  display  a  similar 
defective proliferative response to allogeneic stimulator cells in both spleen and lymph 
nodes. Whether this reduced alloreactivity reflects decreased IL-2 production during 
the allogeneic MLR has not been directly tested in our experiments, but it is evident 
that the response to exogenous IL-2 in the MLR is defective. In contrast, spleen cells 
of older MRL/I mice appear to develop normal allogeneic CTL responses, both on 
the population level and in terms of CTLp frequency, in accord with our previous 
studies  (2,  9,  33,  36).  On  the  other  hand,  the  CTLp  frequency  (against  H-2  b 
alloantigens)  in the mesenteric lymph nodes of these mice is greatly reduced, being 
about 12-fold lower than in normal C3H/St mice. The differences in cytolytic activity 
between spleen and lymph node cells may reflect differences in T  cell subset compo- 
sitions in these two organs, as discussed below. 
The Lyt phenotype ofT cells in the lymph nodes of MRL/1 mice has been analyzed 
by ourselves (28) and others (37).  The most conspicuous findings in these studies are 
the almost complete disappearance of the Lyt-23  + subset, the great reduction of Lyt- 
123 + cells, the normal frequencies of strongly Lyt-1  +, cells and the massive increase of 
an  Lyt-"null"  as  detected  by  cytotoxicity testing  (28),  or  a  weakly  Lyt-1  +  (by 
fluorescence-activated cell sorter analysis) (37) T  cell subset. The exact nature of the 
weakly Lyt-1  + cells and  their position  in  the T  cell differentiation scheme are not 
clear. Because the CTL precursors are included within the pool of Lyt-123  + or Lyt- 
23  + T  cells  (38,  39),  the  marked  reduction  in  CTLp  frequency in  the  mesenteric 
lymph nodes of older MRL/1 mice can be explained by the great dilution of these T 
cell subsets by the proliferating weakly Lyt-1  + cells.  A similar analysis of Lyt subsets 
in  MRL/I  splenocytes  is  lacking.  However,  the  proliferation  of T  cells  in  older 
MRL/1 mice is more apparent in lymph nodes than in spleens with ~30:1  and  10:1 
T  to B cell ratios in these two organs, respectively (2, 28). Thus, although the overall ALTMAN ET AL.  805 
production of and response to IL-2 in the spleens of older MRL/I mice are markedly 
reduced, the available IL-2 in this organ, in contrast to lymph nodes, may be enough 
for the generation of CTL against a given alloantigen, considering the fact that only 
1 in 710 T  cells would require the amplifying signal of IL-2 in order to differentiate 
into H-2b-specific CTL. 
The phenotype of IL-2-produeing and  MLR-responding T  cells has been deter- 
mined to be largely Lyt-1  + (38, 40). Whether the defect in IL-2 production involves 
exclusively the  rapidly  proliferating,  immature,  weakly  Lyt-1  ÷  cells  of the  older 
MRL/I mice or whether there exists in addition a defect of the mature, strongly Lyt- 
1  + cells in these mice remains to be determined. The reduced Con A response and IL- 
2 production even in young MRL/1 mice (6 wk old), which do not as yet manifest 
lymphoid hyperplasia, would suggest that even the strongly Lyt-1  +, nonproliferating 
cells of these mice exhibit, to some degree, the above defects. 
An alternative way to explain the defective IL-2 production by T  cells of MRL/I 
mice is related to the role of macrophages in IL-2 production. It has been shown that 
a soluble product, lymphocyte-activating factor (41) or interleukin  1 (5), secreted by 
activated  macrophages,  is  required  for  IL-2  production  (42,  43).  However,  if a 
macrophage defect (primary or secondary, due to the dilution by the proliferating T 
cells)  was  the  underlying reason  for the  reduced IL-2 production,  the  addition  of 
exogenous IL-2 should have bypassed  this defect and  allowed normal proliferative 
responses. However, our studies indicated otherwise. 
Recently, it was reported that  IL-2-dependent lines of T  cells from MRL/I mice 
could  be  established  in  the  absence  of deliberate  exposure  to  antigen  (37).  This 
suggests the existence of IL-2-responsive cells in MRL/I mice. However, our findings 
that only a minority of T  cells in older MRL/I mice respond to IL-2 in vitro suggest 
that  the  lines  established  by  Lewis  et  al.  (37)  were  highly  selected  and  are  not 
necessarily representative of the  abnormally proliferating T  cells of older  MRL/I 
mice. 
To summarize, the studies reported here show that the overall response to Con A 
and production of IL-2 in most SLE mice are defective at one time or another in their 
life.  Because such  defects appear relatively late, after various autoantibodies  have 
appeared in some of these strains of mice such as BWF1 and MRL/n, we conclude 
that  these defects probably are  not  of primary  importance in  the  disease of these 
strains. Similar defects that appear early in male BXSB mice, although possibly due, 
at least  in part, to a  dilution of the responding T  cells by the proliferating B cells, 
may be attributed  to some yet undetermined changes in  T  cell subsets.  The most 
severe defects appear in MRL/I  mice. Because these defects appear,  although to a 
lesser extent, before evidence of abnormal  T  cell proliferation, it is clear that  such 
defects are not entirely caused by the lymphoproliferative disorder. 
It is of interest to note that despite the continuous stimulation of the autoimmune 
mice by a  plethora of autoantigens expected to occur in vivo, in no instance did we 
detect an increased spontaneous (i.e., without mitogen stimulation) IL-2 production 
in vitro, compared with normal mice. The in vivo significance of these findings and, 
moreover, the role of the defects in IL-2 production-response circuit in the etiopath- 
ogenesis of murine lupus, in at least some of these strains, are questions that might be 
answered by future experimentation. 806  INTERLEUKIN 2 DEFECTS IN AUTOIMMUNE MICE 
Summary 
In the studies reported here, we have analyzed the production and consumption of 
T  cell growth factor, more recently termed interleukin 2 (IL-2), as well as some cell- 
mediated  immune  functions, in  murine strains  [MRL,  BXSB, NZB, and  (NZB  × 
NZW)F1] manifesting systemic lupus erythematosus (SLE)-like syndromes. Young (4- 
6 wk) or old (4-8 mo) autoimmune or normal mice were studied and compared with 
regard to the following T  cell functions in vitro after stimulation with concanavalin 
A  (Con A):  (a) mitogenic response;  (b) IL-2 levels in culture supernates; and (c) the 
ability  to  respond  to  and  adsorb  IL-2.  In  addition,  proliferative  activity  in  the 
allogeneic mixed leukocyte culture and frequency of alloreactive cytotoxic T  lympho- 
cyte precursors  (CTLp)  were  analyzed in  some  of these  strains.  Reduced  Con  A- 
induced mitogenic responses and IL-2 production appeared at 3-6 wk of age in the 
early, severe SLE developing strains MRL/Mp-lpr/lpr  (MRL/1) and male BXSB and 
progressed thereafter. Similar defects appeared at  a  later stage in MRL/Mp-+/+ 
and  (NZB ×  NZW)F1 hybrid mice, which develop late disease. Detailed analysis of 
cells from the enlarged lymph nodes and spleens of older MRL/I mice demonstrated 
that such cells:  (a) responded poorly to Con A or allogeneic stimulator cells, even in 
the presence of  exogenous IL-2; (b) did not suppress IL-2 production by normal spleen 
cells;  (c) were relatively incapable of adsorbing or inactivating IL-2; and  (d)  had a 
markedly reduced anti-H-2  b CTLp frequency in the mesenteric lymph nodes but a 
normal one in spleen. These results indicate that the proliferating Thy-1.2  +, Lyt-1  + T 
cells in  MRL/I  mice are  defective in  their responses to  mitogenic stimuli,  in  IL-2 
production, and in expression of acceptor sites for IL-2. The relevance of these defects 
to the MRL/I disease as well as to the role of IL-2 in autoimmunity in general remains 
to be determined. 
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